Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

BACKGROUND: To explore the impact of KRAS, NRAS and BRAF mutations as well as KRAS mutation variants in patients with metastatic colorectal cancer (mCRC) receiving first-line therapy. PATIENTS AND METHODS: A total of 1239 patients from five randomized trials (FIRE-1, FIRE-3, AIOKRK0207, AIOKRK0604,...

Descripción completa

Detalles Bibliográficos
Autores principales: Modest, D. P., Ricard, I., Heinemann, V., Hegewisch-Becker, S., Schmiegel, W., Porschen, R., Stintzing, S., Graeven, U., Arnold, D., von Weikersthal, L. F., Giessen-Jung, C., Stahler, A., Schmoll, H. J., Jung, A., Kirchner, T., Tannapfel, A., Reinacher-Schick, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999563/
https://www.ncbi.nlm.nih.gov/pubmed/27358379
http://dx.doi.org/10.1093/annonc/mdw261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999563/
https://www.ncbi.nlm.nih.gov/pubmed/27358379
http://dx.doi.org/10.1093/annonc/mdw261

Ejemplares similares